Publication | Closed Access

Antipsychotic polypharmacy in the treatment of children and adolescents in the fee-for-service component of a large state medicaid program

Fee-for-service ComponentPsychiatryAdolescent MedicinePediatricsAdolescent Behavioral HealthHealth InsuranceLarge StatePublic HealthChild PsychiatryMedicineAntipsychotic PolypharmacyHealth Services Research